/cloudfront-us-east-2.images.arcpublishing.com/reuters/H2OXGVDX4RIALEGZ3MTV4BHNAY.jpg "Brazil's Anvisa approves Russian Sputnik V vaccine, with conditions")
Brazil's Anvisa approves Russian Sputnik V vaccine, with conditions
A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov
Brazilian health regulator Anvisa on Friday gave the green light for states to import the Russian COVID-19 vaccine Sputnik V, but with conditions attached.
Anvisa's board voted 4-1 to grant the conditional approval after more than seven hours of deliberation, following the recommendation of its technical staff earlier in the day.
Anvisa also voted to approve, again with conditions, the Covaxin shot made by Bharat Biotech, a private company based in the Indian city of Hyderabad.
"SputnikV will arrive in Brazil in July," tweeted Kirill Dmitriev, chief executive of the Russian Direct Investment Fund (RDIF), which markets the Sputnik V vaccine abroad.
Earlier on Friday, Anvisa's technical staff had recommended approving the vaccine but only on certain conditions, such as that it be used only on healthy adults.
